These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36250680)

  • 41. Synergetic enrichment of aggrecan in nucleus pulposus cells by scAAV6-shRNA-mediated knockdown of aggrecanase-1 and aggrecanase-2.
    Mern DS; Thomé C
    Exp Biol Med (Maywood); 2023 Jul; 248(13):1134-1144. PubMed ID: 37354087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
    Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
    J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
    Roughley PJ; Barnett J; Zuo F; Mort JS
    Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes.
    Tortorella MD; Arner EC; Hills R; Easton A; Korte-Sarfaty J; Fok K; Wittwer AJ; Liu RQ; Malfait AM
    J Biol Chem; 2004 Apr; 279(17):17554-61. PubMed ID: 14715656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide.
    Santamaria S; Cuffaro D; Nuti E; Ciccone L; Tuccinardi T; Liva F; D'Andrea F; de Groot R; Rossello A; Ahnström J
    Sci Rep; 2021 Jan; 11(1):949. PubMed ID: 33441904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma.
    Filou S; Stylianou M; Triantaphyllidou IE; Papadas T; Mastronikolis NS; Goumas PD; Papachristou DJ; Ravazoula P; Skandalis SS; Vynios DH
    Biochimie; 2013 Apr; 95(4):725-34. PubMed ID: 23131589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.
    Wang J; Markova D; Anderson DG; Zheng Z; Shapiro IM; Risbud MV
    J Biol Chem; 2011 Nov; 286(46):39738-49. PubMed ID: 21949132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors.
    Tortorella MD; Tomasselli AG; Mathis KJ; Schnute ME; Woodard SS; Munie G; Williams JM; Caspers N; Wittwer AJ; Malfait AM; Shieh HS
    J Biol Chem; 2009 Sep; 284(36):24185-91. PubMed ID: 19586907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) Activity.
    Chijiiwa M; Mochizuki S; Kimura T; Abe H; Tanaka Y; Fujii Y; Shimizu H; Enomoto H; Toyama Y; Okada Y
    Arthritis Rheumatol; 2015 Jun; 67(6):1557-67. PubMed ID: 25709087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
    Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
    Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.
    Demircan K; Topcu V; Takigawa T; Akyol S; Yonezawa T; Ozturk G; Ugurcu V; Hasgul R; Yigitoglu MR; Akyol O; McCulloch DR; Hirohata S
    Biomed Res Int; 2014; 2014():693746. PubMed ID: 25101296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADAMTS-9 in Mouse Cartilage Has Aggrecanase Activity That Is Distinct from ADAMTS-4 and ADAMTS-5.
    Rogerson FM; Last K; Golub SB; Gauci SJ; Stanton H; Bell KM; Fosang AJ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An aggrecanase and osteoarthritis.
    Karsenty G
    N Engl J Med; 2005 Aug; 353(5):522-3. PubMed ID: 16079379
    [No Abstract]   [Full Text] [Related]  

  • 54. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis.
    Majumdar MK; Askew R; Schelling S; Stedman N; Blanchet T; Hopkins B; Morris EA; Glasson SS
    Arthritis Rheum; 2007 Nov; 56(11):3670-4. PubMed ID: 17968948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development.
    Voros G; Sandy JD; Collen D; Lijnen HR
    Biochim Biophys Acta; 2006 Dec; 1760(12):1837-44. PubMed ID: 17011710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of aggrecanase 1 in Lyme arthritis.
    Behera AK; Hildebrand E; Szafranski J; Hung HH; Grodzinsky AJ; Lafyatis R; Koch AE; Kalish R; Perides G; Steere AC; Hu LT
    Arthritis Rheum; 2006 Oct; 54(10):3319-29. PubMed ID: 17009305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
    Bondeson J; Lauder S; Wainwright S; Amos N; Evans A; Hughes C; Feldmann M; Caterson B
    J Rheumatol; 2007 Mar; 34(3):523-33. PubMed ID: 17295438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.
    Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G
    J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADAMTS: a novel family of extracellular matrix proteases.
    Tang BL
    Int J Biochem Cell Biol; 2001 Jan; 33(1):33-44. PubMed ID: 11167130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.